Stockscreener 앱 받기
4.505
5.50%
0.235
시간 외 거래:
4.67
0.165
+3.66%
Bioatla Inc 주식(BCAB)의 최신 뉴스
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Highs Report: What is the dividend yield of BioAtla IncPortfolio Performance Report & Verified Technical Signals - baoquankhu1.vn
BCAB Technical Analysis | Trend, Signals & Chart Patterns | BIOATLA INC (NASDAQ:BCAB) - ChartMill
BioAtla Announces 1-for-50 Reverse Stock Split Merger - The Globe and Mail
[8-K] BioAtla, Inc. Reports Material Event - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Sahm
BioAtla To Carry Out 1-for-50 Reverse Stock Split On April 6th, 2026 - Moomoo
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - The Manila Times
BioAtla announces 50-for-1 reverse stock split effective April 6 - Investing.com Australia
BioAtla announces 50-for-1 reverse stock split effective April 6 By Investing.com - Investing.com South Africa
BioAtla Begins Strategic Review Following 2025 Results - TipRanks
BioAtla Announces 50-for-1 Share Consolidation - National Today
BioAtla Announces Share Consolidation - Investing News Network
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
BioAtla to implement 50-for-1 share consolidation - MSN
BioAtla Q4 net loss narrows on lower expenses - TradingView
BRIEF-BioAtla Q4 Net Income USD -9.784 Million - TradingView
Strategic shake-up at BioAtla (NASDAQ: BCAB) as oncology pipeline and funding plans are reassessed - Stock Titan
BioAtla (NASDAQ: BCAB) posts 2025 loss, launches asset monetization review - Stock Titan
Aug Decliners: How much upside does BioAtla Inc haveCPI Data & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
BioAtla, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Aug Wrap: Will BioAtla Inc stock hit new highs in YEAR2026 Bull vs Bear & AI Based Trade Execution Alerts - baoquankhu1.vn
BCAB Stock Price, Quote & Chart | BIOATLA INC (NASDAQ:BCAB) - ChartMill
Signal Recap: How much upside does BioAtla Inc have2026 Sector Review & Stepwise Swing Trade Plans - baoquankhu1.vn
Buyout Rumor: Can BioAtla Inc deliver consistent dividends2026 Decliners & Risk Managed Investment Signals - baoquankhu1.vn
BioAtla Shareholders Approve Merger and Share Consolidation - The Globe and Mail
BioAtla, Inc. 8-K SEC Filing March 17, 2026: Company Information, Key Details, and Legal Disclosures - Minichart
BioAtla (NASDAQ: BCAB) approves merger, 1-for-50 reverse split and 2026 executive retention bonuses - Stock Titan
842,440 shares issued to YA II PN, Ltd.; BioAtla (NASDAQ: BCAB) registers resale - Stock Titan
Breakout Watch: What is the dividend yield of BioAtla IncEarnings Growth Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
BioAtla (NASDAQ: BCAB) to issue 631,163 shares to Yorkville under SEPA - Stock Titan
BioAtla (NASDAQ: BCAB) CMO receives 240,000-share time-based RSU award - Stock Titan
BioAtla (NASDAQ: BCAB) CEO receives 430,000-share RSU grant - Stock Titan
BioAtla (BCAB) CFO awarded 240,000 restricted stock units, total holdings 530,196 shares - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Published on: 2026-03-07 14:29:43 - Naître et grandir
BioAtla Stock Slips Premarket After Early Pop As Investors Weigh $40M SPV Deal For Phase 3 Cancer Trial - Stocktwits
BioAtla launches major restructuring and leadership transition - The Globe and Mail
BioAtla explores sale as it cuts 70% of workforce - Investing.com South Africa
BioAtla (BCAB) CFO sees 1,802 shares withheld for RSU tax settlement - Stock Titan
[Form 4] BioAtla, Inc. Insider Trading Activity - Stock Titan
BioAtla (BCAB) CMO reports 3,140-share tax withholding on RSU vesting - Stock Titan
BioAtla explores sale as it cuts 70% of workforce By Investing.com - Investing.com India
BioAtla, Inc. Initiates Strategic Review Process and Workforce Restructuring to Enhance Shareholder Value - Quiver Quantitative
BioAtla Inc announces 70% workforce reductionSEC filing - marketscreener.com
BioAtla appoints Chris Vasquez as CFO as Richard Waldron departs - TradingView
BioAtla (NASDAQ: BCAB) slashes workforce 70% amid strategic review, listing risk - Stock Titan
BioAtla, Inc. Implements Workforce Reduction of Approximately 70% - marketscreener.com
Bioatla announces formal process to evaluate strategic options to monetize assets - marketscreener.com
Bioatla Announces Formal Process To Evaluate Strategic Options To Monetize Assets - TradingView
Biotech BioAtla to shed 70% of staff while weighing asset sales - Stock Titan
BCAB PE Ratio & Valuation, Is BCAB Overvalued - Intellectia AI
2.69%
0.25%
자본화:
|
볼륨(24시간):